The Technology Driven data channels offers a key opportunity for pharma companies to restructure their sales and marketing model, improving their relationships with physicians and increasing compliance among patients. At the same time, patients are demanding a greater role in treatment decisions and seeking information from a range of online sources, resulting in a new age of consumerism in healthcare. If you take a look at the screenshots below, you will realize the biggest problems for Pharma companies today where mhealth can be a solution. Courtesy- Businessmonitor . Potential areas where Mhealth can be of use and can be deployed to tap the captive market driving non linear revenue. As far as returns are concerned in the Pharma sector in India, India has one of the largest pharmaceutical markets in Asia, currentlyvalued at US$16.32bn. However, due to the country’s vast 1.17bn population, individual spending is actually very low. Pharmaceutical expenditure in 2009 was 1.24% of ...
#MachineLearning, #BigData analytics, #ArtificialIntelligence have made the space of #digital #health even more interesting. Emerging markets like India are taking on these learning and bringing exciting business models. This blog is about Dr Dass's involvement in such projects and case studies. more on www.healthcursor.com